Orkin C, Arastéh K, Hernández-Mora MG et al. Long-acting cabotegravir + rilpivirine for hiv maintenance: FLAIR week 48 results. CROI 2019, abstract 140LB.
First-in-human trial naar oraal vectorvaccin tegen hiv-1
dec 2018 | HIV, Vaccinatie, Virale infecties